The aim of this study was to evaluate the e ect of modifying the cu on preventing ventilator-associated pneu (VAP). PubMed, Embase and Cochrane Library were systematically searched from inception to April 2022, for randomised controlled trials (RCTs) that compared the e ect of a new type of cu intubation with traditional cu intubation on VAP incidence and intensive-care unit (ICU) mortality in mechanically ventilated patients. Nine RCTs with 1937 patients were nally evaluated. The pooled results for the incidence of VAP showed that the modi ed cu signi cantly decreased the morbidity of VAP compared with the traditional cu (relative ratio (RR) = 0.73, 95% con dence interval (CI) 0.56 0.95, p = 0.02). The subgroup analysis revealed that polyurethane (PU) cu (RR = 0.82, 95% CI 0.46 1.48, p = 0.52), conical cu (RR = 0.97, 95% CI 0.73 1.28, p = 0.82) and PU-conical cu (RR = 1.36, 95% CI 0.85 2.18, p = 0.20) did not decrease the incidence of VAP. Moreover, the improved cu combined with subglottic secretion drainage (SSD) could signi cantly reduce the VAP incidence (RR = 0.58, 95% CI 0.44 0.77, p = 0.0001). In terms of ICU mortality, there was no statistically signi cant di erence (RR = 0.83, 95% CI 0.68 1.02, p = 0.0b8e)tween the two groups. The modi ed cu is superior to the traditional cu in VAP prevention. In particular, the modi ed cu combined with subglottic secretion drainage has more advantages.